Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer—Results from the AGMT GASTRIC-5 Registry

Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer—Results from the AGMT GASTRIC-5 Registry

Trastuzumab in combination with a platinum and fluorouracil is the treatment of choice for patients with advanced human epidermal growth factor receptor 2 (HER2) positive gastric cancer and gastroesophageal junction (GEJ) cancer. Pathological assessment of the HER2 status in gastric/GEJ cancer, howe...

Full description

Bibliographic Details
Main Authors: Florian Huemer, Lukas Weiss, Peter Regitnig, Thomas Winder, Bernd Hartmann, Josef Thaler, Gudrun Piringer, Clemens A. Schmitt, Wolfgang Eisterer, Hannes Gänzer, Alois Wüstner, Johannes Andel, Björn Jagdt, Hanno Ulmer, Richard Greil, Ewald Wöll
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Journal of Clinical Medicine
Subjects:
gastric cancer
gastroesophageal cancer
HER2
concordance
discordance
Online Access:https://www.mdpi.com/2077-0383/9/4/935

Internet

https://www.mdpi.com/2077-0383/9/4/935

Similar Items